Source: International Congress 2017 – New insights into pathogenesis of lung disease 
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Hodge (Adelaide, SA, Australia). Steroid resistant CD28nullCD8+NKT-like pro-inflammatory cells in COPD. 2017

Member's Comments

No comment yet.

Related content which might interest you: Effects of dexamethasone and anti-inflammatory drugs on inflammatory cytokines from bronchial epithelial cells of COPD patients Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Lymphocyte senescence in COPD is associated with decreased sirtuin 1 expression in steroid resistant pro-inflammatory lymphocytes Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Pulmonary inflammatory cells strongly express IL-18 in asthma death cases Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma Year: 2008 Proinflammatory cytokines in induced sputum and COPD phenotype Source: Annual Congress 2011 - COPD: human studies Year: 2011 Leptin and inflammatory cytokines during COPD exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 252s Year: 2002 Anticholinergic treatment does not affect toll-like receptor 3-induced antiviral immune response in COPD bronchial epithelial cells Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Sputum macrophages in chronic bronchitis are activated, steroid resistant and drive epithelial MUC5B Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020 Steroid insensitivity of airway T lymphocytes in COPD patients Source: Annual Congress 2009 - Pathology and immunology of COPD Year: 2009 Steroid resistant asthma Source: Annual Congress 2004 - PG8 - Defining clinical asthma phenotypes: implications for therapy Year: 2004 Antiviral biomarkers are upregulated in sputum cells following administration of inhaled interferon beta to COPD patients Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019 Macrolide effects on the prevention of COPD exacerbations Source: Eur Respir J 2012; 40: 485-494 Year: 2012 Effects of JAK-STAT inhibitors on glucocorticosteroid resistant release of CXCR3 chemokines from human bronchial epithelial cells Source: Annual Congress 2011 - Epithelial cell biology Year: 2011 Pro-inflammatory / anti-inflammatory capacity of lymphocyte cells in COPD Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019 Dynamic of proinflammatory cytokines system and nonspecific markers of inflammation in patients with COPD before and after treatment with broncholitics Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006 Glucocorticoid sensitivity of LPS stimulated COPD alveolar macrophages Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 Steroid resistance in COPD is associated with impaired molecular chaperone HSP90 expression by pro-inflammatory lymphocytes Source: International Congress 2016 – Mechanisms of disease Year: 2016 Statins suppress LPS-induced proinflammatory cytokine production from human bronchial epithelial cells Source: Annual Congress 2009 - Epithelial cell biology Year: 2009 Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 551s Year: 2006 Extracellular Hsp70 modulates inflammatory response in PBEC cells from COPD patients Source: International Congress 2018 – COPD: immune regulation and therapeutic targets Year: 2018 IL-8 and TSLP production as markers of bronchial epithelial cell activation in IL-17A mediated airway inflammation in COPD: Role of tiotropium Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung Year: 2013